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OBJECTIVE — Diabetes negatively impacts the health-related quality of life (HRQOL) of
patientswithtype2diabetes.AnearlieranalysisshowedHRQOLtobeassociatedwithmortality,
which suggests that measuring HRQOL could have clinical implications. We studied the asso-
ciation between HRQOL and total and cardiovascular mortality in patients with type 2 diabetes
during long-term follow-up and speciﬁcally focused on old age and sex differences.
RESEARCH DESIGN AND METHODS — HRQOL was measured in a prospectively
followedcohortof1,353patientswithtype2diabetesusingtheRAND-36.Coxproportional
hazard models were used to measure the independent effect of baseline HRQOL on
mortality.
RESULTS — During a mean follow-up of 9.6 years, 570 (42%) patients died, 280 of whom
died of cardiovascular disease (49%). The Physical Component Score (PCS) and the Mental
Component Score (MCS) were inversely associated with total mortality, with hazard ratios of
0.988(95%CI0.983–0.993)and0.990(95%CI0.985–0.995),respectively.A10-point-higher
scoreonthePCSandMCSdecreasedtheriskfortotalmortalityby11and10%,respectively.An
inverse relationship with mortality was also seen for men, women, and for patients aged 75
years. Mental health was signiﬁcantly related to mortality in men but not in women.
CONCLUSIONS — Lower physical and mental HRQOL was associated with a higher total
mortalityandcardiovascularmortalityinpatientswithtype2diabetes;thisisalsothecasewhen
studying men and women and the elderly separately. The dimension mental health, related to
depression and anxiety, was only associated with mortality in men, not in women.
Diabetes Care 33:2378–2382, 2010
D
iabetes often leads to the develop-
ment of physical disabilities that, in
turn, can have a detrimental effect
on a patient’s quality of life (QOL) (1).
The importance of optimizing health-
related QOL (HRQOL) has increasingly
been recognized, not only because it rep-
resents an important goal for health care
on its own but also because of the associ-
ationsbetweenpoorHRQOLandadverse
outcomes in people with type 2 diabetes,
including poor response to therapy, dis-
ease progression, and even mortality
(2–6).
The relationship between HRQOL
and mortality in patients with diabetes
has been investigated previously in three
studies (4–6). Lo ´pez Revuelta et al. (4)
showed perceived mental health to be an
independent predictor of morbidity and
mortality in patients with end-stage renal
disease. Most of the patients in this study
had diabetes (65%). In a recently pub-
lished study, the EQ-5D questionnaire
was used to study the relationship be-
tween HRQOL and mortality, and lower
HRQOL was associated with a higher
mortality rate (5). Our study group previ-
ously showed the physical component
summary of the RAND-36 to be an inde-
pendent marker for total mortality in pa-
tients with type 2 diabetes (6). The
investigators in two of three aforemen-
tioned studies reported results for indi-
vidual health dimensions (4,6). Physical
functioning and general health in Kleef-
stra et al.’s study (6) and general health,
mental health, and role limitations due to
emotional problems in Lo ´pez Revuelta et
al.’s study (4) were associated with total
mortality. Although previous studies
(7–9) have shown an inverse relationship
between HRQOL and mortality in the el-
derly population, no study has speciﬁ-
callyfocusedonelderlypatientswithtype
2 diabetes. Traditional risk factors be-
come less predictive of mortality at in-
creasing age (10). HRQOL is therefore of
interest for elderly patients and may be-
come increasingly important to clinicians
for its predictive value.
After these three studies, questions
still remain regarding the relationship be-
tween the different health dimensions
and mortality, the relationship between
HRQOL and mortality in elderly patients
with type 2 diabetes, and whether the re-
lationship between HRQOL and mortal-
ity is different between men and women.
The purpose of this study was to revisit
the association between HRQOL and
mortality after a longer follow-up period
(10 years), with a special focus on the el-
derly (aged 75 years) and on possible
sex differences.
RESEARCH DESIGN AND
METHODS— In 1998, in the Zwolle
regionoftheNetherlands,alargediabetes
project was initiated. In the Zwolle Out-
patient Diabetes Project Integrating
Available Care (ZODIAC), general practi-
tioners were assisted by hospital-based
diabetes specialist nurses in providing
care for patients with type 2 diabetes. As
part of this project, patients with type 2
diabetesin32primary-carepracticescon-
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nurses on an annual basis. Patients with a
very short life expectancy (including pa-
tients with active cancer) and patients
with insufﬁcient cognitive abilities were
excludedfromthestudy.Allpatientswith
type 2 diabetes were identiﬁed during the
ﬁrst 2 years of the project. Any patients
beingtreatedbyaninternalmedicinespe-
cialist (20%) were excluded, as they were
nolongerintheprimary-caresetting.Five
percent of patients were excluded be-
causeofashortlifeexpectancyorbecause
they had insufﬁcient cognitive abilities to
complete the necessary questionnaires. A
total of 1,353 (90%) patients agreed to
participate in the study. The ZODIAC
study was approved by the medical ethics
committee, and all patients provided in-
formed consent. The details of this study
have been published previously (11).
Baseline data, collected in 1998 and
1999, included the RAND-36 question-
naires,afullmedicalhistoryincludingthe
presence or absence of macrovascular
complications,theuseofmedication,and
tobacco consumption. Laboratory and
physical assessment data were collected
annually and included a lipid proﬁle,
A1C, serum creatinine, urinary albumin,
urinary creatinine, blood pressure,
weight,andheight.Subsequently,lifesta-
tus and causes of death were retrieved
from the records maintained by the hos-
pital and the general practitioners. The
causes of death were coded according to
theICD-9.
TheRAND-36isconsideredageneric
measure as it is used to assess aspects of
healththatarerelevanttoanyindividual’s
functional status and well being (12,13).
The RAND-36 consists of 36 questions
covering nine aspects of health status:
physical functioning, role limitations due
to physical health problems, bodily pain,
generalhealth,vitality,socialfunctioning,
role limitations due to emotional prob-
lems, mental health, and health change.
The scores for questions relating to each
scale are summed and rescaled to a 100-
pointscale,where100isthebestpossible
score and 0 the worst. The nine scales in
the RAND-36 can further be divided into
two component summaries: a physical
component summary (PCS) and a mental
component summary (MCS) (12). Low
PCS scores indicate substantial limita-
tions in self-care, physical and social ac-
tivities, severe bodily pain, or frequent
tiredness. Low MCS scores indicate fre-
quentpsychologicaldistressandsubstan-
tial social and role limitations due to
emotional problems.
To study mortality, standardized mor-
talityratioswerecalculatedfortotalandcar-
diovascular mortality using general
mortality reference rates from the Nether-
lands (http://statline.cbs.nl/statweb/). Cox
proportional hazard modeling was used to
assesstheassociationbetweenHRQOLand
total mortality and cardiovascular mortal-
ity. The health dimensions and component
scales all have a different mean value be-
tweencountries.Comparingscalesbetween
countries is difﬁcult; therefore, we trans-
formed the scales. The transformation used
is a linear T-score transformation with ref-
erence data from the Netherlands (14),
which has the advantage of making the dif-
ferent dimensions of health easier to inter-
pret without further reference to normative
data(12,15).Thisresultsinscoresforallthe
dimensions and the summary scores to
have a mean (SD) of 50  10. The use of
the same mean and SD for purposes
of transforming scores has the advantage of
permitting comparisons of mean scores for
HRQOL across countries (16).
A model was constructed that in-
cluded all possible confounders in the
analysis (see below). Separate analyses
were performed to study the effect of age
and sex on mortality. For the age-speciﬁc
analysis, patients were stratiﬁed into two
age-groups, those aged 75 years and
thoseaged75years.Forthesex-speciﬁc
analysis, we investigated whether signiﬁ-
cant interaction takes place between sex
and HRQOL. Subsequently, we per-
formedmultivariateanalysesstratiﬁedac-
cording to sex. The following variables as
possible confounders were included (age,
sex, smoking [yes/no], duration of diabe-
tes, serum creatinine, BMI, systolic blood
pressure, total-to-HDL cholesterol ratio,
macrovascular complications [yes/no],
use of statins [yes/no], insulin use [yes/
no], and urinary albumin-to-creatinine
ratio). The proportional hazards assump-
tion was examined using log (log) sur-
vival plots. The parallel lines in the plots
indicate that the assumption was met. All
tests were two sided, and analyses were
performed with SPSS, version 15.0.1
(SPSS, Chicago, IL).
RESULTS— Patient characteristics at
baseline are presented in Table 1. After a
median follow-up period of 9.6 years,
570 of 1,353 patients had died (42%).
Life status was not known for 20 patients
(1%), and causes of death were unknown
for 29 patients (5%); 238 deaths (42%)
hadcardiovascularcausesand122deaths
(21%) were due to cancer. HRQOL data
wereavailableandcompletefor1,053pa-
tients (78%). The standardized mortality
ratios (95% CIs) for total mortality and
cardiovascular mortality were 2.35 (95%
CI 1.77–3.04) and 2.67 (2.36–3.05).
Thehazardratios(HRs)fortotalmor-
tality for the PCS and MCS were 0.988
(95% CI 0.983–0.993) and 0.990
(0.985–0.995), respectively. A one-
point-higher score on the PCS and MCS
decreasestheriskformortalityby1.2and
1.0%,respectively.Thismeansthataclin-
Table 1—Baseline characteristics
Characteristics Total
Deceased
patients Survived patients
n 1,353 570 783
Age (years) 67.8  11.7 75.3  8.6 62.4  10.6†
Female (%) 57.6 57.2 57.9
Diabetes duration (years) 6 (3–11) 7 (3–13) 5 (2–10)†
Smoking (%) 18.6 14.8 21.4
BMI (kg/m²) 28.9  4.8 28.3  4.7 29.4  4.7†
Systolic blood pressure (mmHg) 153  25 156  27 152  24*
A1C (%) 7.5  1.2 7.4  1.3 7.5  1.2
Creatinine clearance (ml/min) 73.9  28.1 60.3  22.2 83.8  27.9†
Total-to-HDL ratio 5.2  1.6 5.1  1.6 5.2  1.5
Albumin-to-creatinine ratio 2.1 (1.0–7.2) 3.9 (1.4–12.3) 1.6 (0.9–4.4)†
Macrovascular complications (%) 32.7 46.1 23.0†
Age 75 years (%) 27.6 53.3 8.9†
PCS score 71.6 (48.7–86.7) 61.3 (41.5–80.5) 76.8 (55.8–89.2)†
MCS score 76.8 (59.3–87.6) 71.3 (52.3–84.1) 79.8 (61.8–88.8)†
DataaremeansSDfornormallydistributeddata,median(interquartilerange)fornonnormallydistributed
data, or percent. *P  0.05; †P  0.001.
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higher score, on a 100-point scale, on the
PCSandMCS,decreasedtheriskformor-
talityby11%(0.988tothepower10)and
10%, respectively.
For cardiovascular mortality, the HRs
of PCS and MCS were 0.988 (95% CI
0.977–0.999) and 0.987 (0.975–0.999),
respectively. Eight of nine health dimen-
sions were related to total mortality, and
ﬁve health dimensions were associated
with cardiovascular mortality (Table 2).
Elderly patients
PCS and MCS were also inversely associ-
ated with mortality in the subgroup of el-
derly patients (aged 75 years) with HRs
of 0.989 (95% CI 0.981–0.996) and
0.991(0.984–0.999),respectively(Table
3). For the subgroup of younger patients
(aged 75 years), HRs for PCS and MCS
were 0.987 (0.980–0.993) and 0.988
(0.981–0.995), respectively. In the sub-
group of elderly patients, three of nine
health dimensions were inversely associ-
ated with total mortality with lowest HRs
for physical functioning and general
health perception.
Sex-related differences
We found a signiﬁcant interaction be-
tween mental health and sex (P  0.042)
(Table 4). After adding the interaction
termbetweensexandmentalhealthtothe
model, the association between mental
health and total mortality became more
pronounced (HR 0.976 [95% CI 0.960–
0.994]).ThePCSandMCSwereinversely
associated with total mortality for both
women and men. For female patients, the
HRs were 0.988 (0.982–0.994) and
0.992 (0.985–0.998) for PCS and MCS,
respectively. For male patients, the HRs
for PCS and MCS were 0.988 (0.981–
0.996) and 0.987 (0.979–0.995).
A total of six of nine health dimen-
sions were related to total mortality for
women and ﬁve of nine for men. There
were three differences: the health dimen-
sion role functioning (physical) was sig-
niﬁcantly related to mortality in women
but not in men, and bodily pain was sig-
niﬁcantly related to women but not in
men,althoughabsoluteHRsdidnotreally
differ. Mental health was signiﬁcantly re-
lated to mortality in men but not in
women, with notable differences also in
HR (0.984 [95% CI 0.976–0.992]) vs.
0.998 (0.992–1.004). When looking at
the individual ﬁve questions from which
the mental health dimension is com-
posed, all ﬁve relating to depression and
anxiety, these ﬁve questions were related
to mortality in men but none in women
(data not shown).
Analyzing of the model with the vari-
able “incomplete questionnaire” (instead
oftheRAND-36scores),patientswhodid
not complete the RAND-36 had an in-
creased total mortality risk compared
with patients who completed the ques-
tionnaire. When excluding the ﬁrst 2
years of follow-up, the relationship be-
tweenthetwocomponentsummariesand
total and cardiovascular mortality was
stillpresentanddidnotrelevantlychange
(data not shown). Survival was also pre-
dicted by the factors age, sex, serum cre-
atinine, and albumin-to-creatinine ratio.
The proportional hazard assumptions
were met for all analyses.
CONCLUSIONS — After a median
follow-up period of almost 10 years, total
and cardiovascular mortality was in-
creased for type 2 diabetic patients who
had a lower HRQOL at baseline. Both the
PCS and MCS were related to total and
cardiovascular mortality regardless of
confounders such as age and sex. A 10-
point-higher score, on a 100-point scale,
on the PCS and MCS decreased the risk
formortalityby11and10%,respectively.
These effects appear to be clinically rele-
vant and comparable with a 1% decrease
in A1C (17). Our study supports the rec-
ommendations to include measurement
and integration of health status in clinical
practice (18,19). As it is difﬁcult to inter-
pret the applicability of our results into
Table 2—Relationship between HRQOL and total and cardiovascular mortality
RAND-36 dimensions
1-point higher score
HR (95%CI)* HR (95%CI)*
Total mortality Cardiovascular mortality
PCS 0.988 (0.983–0.993) 0.988 (0.977–0.999)
MCS 0.990 (0.985–0.995) 0.987 (0.975–0.999)
Physical functioning 0.988 (0.984–0.991) 0.988 (0.979–0.997)
Social functioning 0.992 (0.988–0.996) 0.996 (0.986–1.006)
Role functioning, physical 0.996 (0.993–0.999) 0.995 (0.991–0.999)
Role functioning, emotional 0.997 (0.994–0.999) 0.994 (0.988–0.999)
Mental health 0.993 (0.989–0.998) 0.987 (0.976–0.998)
Bodily pain 0.994 (0.991–0.998) 0.998 (0.989–1.008)
Vitality 0.993 (0.989–0.998) 0.995 (0.984–1.006)
General health perception 0.984 (0.978–0.991) 0.979 (0.962–0.995)
Health change 0.997 (0.992–1.003) 1.008 (0.994–1.022)
*Corrected for age, sex, smoking, duration of diabetes, serum creatinine, BMI, systolic blood pressure,
total-to-HDL cholesterol ratio, macrovascular complications, use of statins, insulin use, and urinary albu-
min-to-creatinine ratio. Signiﬁcant relationships are indicated in bold.
Table 3—Relationship between HRQOL and total mortality stratiﬁed according to age
RAND-36 dimensions
1-point higher score
HR (95%CI)* HR (95%CI)*
Total mortality
(aged 75 years)
Total mortality
(aged 75 years)
PCS 0.989 (0.981–0.996) 0.987 (0.980–0.993)
MCS 0.991 (0.984–0.999) 0.988 (0.981–0.995)
Physical functioning 0.985 (0.979–0.992) 0.988 (0.983–0.993)
Social functioning 0.992 (0.987–0.997) 0.990 (0.985–0.996)
Role functioning, physical 0.997 (0.993–1.000) 0.994 (0.991–0.998)
Role functioning, emotional 0.998 (0.994–1.001) 0.996 (0.992–0.999)
Mental health 0.995 (0.988–1.003) 0.992 (0.985–0.999)
Bodily pain 0.995 (0.989–1.000) 0.993 (0.988–0.998)
Vitality 0.996 (0.989–1.003) 0.992 (0.986–0.998)
General health perception 0.983 (0.973–0.994) 0.984 (0.975–0.993)
Health change 0.997 (0.987–1.006) 0.999 (0.991–1.006)
*Corrected for age, sex, smoking, duration of diabetes, serum creatinine, BMI, systolic blood pressure,
total-to-HDL cholesterol ratio, macrovascular complications, use of statins, insulin use, and urinary albu-
min-to-creatinine ratio. Signiﬁcant relationships are indicated in bold.
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female patient has a score of 40 on the PCS,
this means that her absolute score is 10
points lower than the mean (using the T-
scoretransformation,thePCShasameanof
50). Her HR for mortality would be 11.4%
higher (0.988 to the power of 10).
In our previous study, which had a
median follow-up period of 5.8 years, the
only signiﬁcant association we found was
between the PCS score and total mortal-
ity, and two separate health dimensions:
‘physical functioning’ and ‘general health
perception’ (6). The association between
the MCS score and mortality was 1.008
(CI 0.994–1.022). In our present study,
with almost 10 years of follow-up, the re-
lationship is quite different, and MCS is
now inversely associated with mortality.
This may imply that low MCS scores can
only predict mortality after a longer fol-
low-up period. Furthermore, the rela-
tionships between the separate health
dimensions and mortality have become
more pronounced, with most dimensions
being inversely related to mortality.
For the sex-speciﬁc analysis, an inter-
esting interaction between mental health
andsexexisted.Suchaninteractioncould
mean that sex has an effect on the rela-
tionship between mental health and mor-
tality. Stratiﬁcation for sex revealed one
relevant difference: mental health was re-
lated to mortality in men only. A 10-
point-higher score on the dimension
mental health decreased mortality risk
with 15% in men. At baseline, women
ratedtheirmentalhealthworsethanmen,
with a median score of 79 vs. 71 in men
(P  0.001). Patients with decreased
scores on the mental health dimension
have symptoms related to depression and
anxiety (20). This difference between
men and women in our cohort could im-
ply that poorer mental health, although
less prevalent in man compared with
women, has a greater effect on mortality
in men. The individual questions from
which the mental health dimension is
composed are related to depression and
anxiety, and there is some evidence in a
nondiabetic population that depression
effects mortality risk in men more than in
women (21).
In the age-speciﬁc analysis, in which
we stratiﬁed for age, many associations
werenotsigniﬁcantforpatientsaged75
years. However, these differences do not
seem to be clinically relevant and are
probably caused by the reduction in sam-
ple size after stratiﬁcation. According to
the various subgroup analyses, the health
dimensions physical functioning, social
functioning, and general health were the
most consistent predictors for mortality.
Previous studies (22,23) have shown that
a patient’s self-rated health status is con-
sistently associated with mortality.
Due to this study’s observational de-
sign, it is not clear whether there is a true
causal relationship between HRQOL and
mortality. The question remains whether
HRQOL is a modiﬁable risk factor or just
a marker of disease burden. No random-
ized controlled trials have been per-
formed in which an attempt was made to
speciﬁcally improve HRQOL speciﬁcally.
Whether HRQOL is a causal factor for
mortality, we ﬁrst would need to identify
a possible treatment strategy to improve
HRQOL. A recent meta-analysis could
not identify psychosocial interventions
with clinically relevant beneﬁt with re-
gard to physical and mental health in pa-
tients with diabetes (24). Developing
such strategies remains an important
challengeandcouldhaveimplicationsfor
the understanding of interaction between
physical and mental health. Patients with
diabetes are also more prone to depres-
sion compared with patients without dia-
betes (25). The dimension mental health
is correlated to depression (13), and de-
pression is independently associated with
a lower HRQOL and mortality (25);
hence, one could hypothesize that treat-
ing depression, and indirectly HRQOL,
may increase survival. Such a hypothesis
needstobeinvestigated,however.Several
trials have been performed in depressed
patients following a myocardial infarc-
tion, but all interventions applied did not
increase survival (26).
There are additional limitations to
our study. Twenty-two percent of our pa-
tient population did not complete the
RAND-36 questionnaire. As not complet-
ing the questionnaire was associated with
an increased mortality, it is likely that the
relationships between the HRQOL in-
dexes and (cardiovascular) mortality are
underestimated in this study. There may
also be additional confounders, such as de-
pression and social economic status, which
we did not take into account and which
may, therefore, have inﬂuenced the out-
come (25). Furthermore, no adjustments
were made for a history of diseases other
than cardiovascular disease. However, after
excludingtheﬁrst2yearsoffollow-upfrom
the analysis, the relationship between
HRQOL and (cardiovascular) mortality re-
mained largely unchanged. Excluding the
ﬁrst 2 years of follow-up could correct for
severe comorbidity or undiagnosed cancer
at the start of the study, which could have
inﬂuenced outcome.
Speciﬁc strengths of our study in-
cludetheprospectivenatureofthedesign
andafollow-upperiodofalmost10years.
The number of deaths after the 10-year
period was sufﬁcient to allow reliable es-
timatesofassociationswithmortality.We
also performed a T-score transformation,
which has the advantage of permitting
comparisons of mean scores for health in
different countries (15).
Our study shows that a decrease in
HRQOL is associated with an increase in
(cardiovascular) mortality among young
as well as elderly type 2 diabetic patients.
HRQOL instruments may become an in-
creasingly useful clinical tool to not only
identifythosepatientswithalowHRQOL
Table 4—Relationship between HRQOL and total mortality stratiﬁed according to sex
RAND-36 dimensions
1-point higher score
HR (95%CI)* HR (95%CI)*
Male subjects Female subjects
PCS 0.988 (0.981–0.996) 0.988 (0.982–0.994)
MCS 0.987 (0.979–0.995) 0.992 (0.985–0.998)
Physical functioning 0.988 (0.983–0.994) 0.988 (0.982–0.993)
Social functioning 0.990 (0.984–0.996) 0.993 (0.988–0.998)
Role functioning, physical 0.997 (0.993–1.001) 0.996 (0.993–0.999)
Role functioning, emotional 0.996 (0.992–1.001) 0.997 (0.994–1.000)
Mental health 0.984 (0.976–0.992) 0.998 (0.992–1.004)
Bodily pain 0.994 (0.989–1.000) 0.994 (0.989–0.999)
Vitality 0.993 (0.987–0.999) 0.993 (0.988–0.999)
General health perception 0.986 (0.976–0.996) 0.983 (0.974–0.992)
Health change 0.998 (0.989–1.006) 0.997 (0.989–1.004)
*Corrected for age, smoking, duration of diabetes, serum creatinine, BMI, systolic blood pressure, total-to-
HDL cholesterol ratio, macrovascular complications, use of statins, insulin use, and urinary albumin-to-
creatinine ratio. Signiﬁcant relationships are indicated in bold.
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associated increase in mortality risk. This
study supports the clinical predictive use
ofHRQOLmeasuresincombinationwith
the well established risk factors for the
assessment of mortality risk for patients
type 2 diabetes.
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